Exiqon Diagnostics, Inc. Announces BRAF Mutation Analysis for Predicting Therapeutic Response in Colorectal Cancer Patients
7/8/2009 8:37:02 AM
More...
|
Exiqon Diagnostics, Inc. Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
5/29/2009 11:04:01 AM
More...
|
Exiqon Diagnostics, Inc. Announces KRAS Mutation Analysis for Predicting Therapeutic Response in Colorectal and Non-Small Cell Lung Cancer Patients
5/11/2009 9:39:59 AM
More...
|
Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech to Exiqon Diagnostics, Inc.
10/16/2008 11:16:59 AM
More...
|